Clinlab Navigator

Isocitrate Dehydrogenase Mutations

Isocitrate dehydrogenase (IDH) normally catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate. IDH1 is a cytosolic enzyme that results in production of NADPH. It should not be confused with IDH2 which is an isoenzyme in the citric acid cycle that reduces NAD rather than NADP.  Mutations in IDH1 and IDH2 occur in a number of cancer types including ~20% of acute myeloid leukemias (AML).  IDH mutants gain the novel capacity to reduce α-ketoglutarate to D-2-hydroxyglutarate. D-2-hydroxyglutarate is known as an oncometabolite and its accumulation competitively inhibits α-ketoglutarate dependent enzyme activities including methlycytosine hydroxylation by members of the TET gene family and histone lysine demethylases belonging to the JMJD family. Such metabolic derangement promotes genetic hypermethylation and in the case of AML, leads to arrested differentiation of myeloid progenitors. 

IDH mutations have been identified in over 70% of lower-grade (II/III) diffuse gliomas and secondary glioblastoma. Assessment of IDH mutation status in central nervous system tumors assists in tumor classification and provide prognostic information for patients with diffuse gliomas.

Point mutations and small insertion/deletion mutations in the IDH1 and IDH2 genes are detected by next generation sequencing. Enasidenib and Ivosidenib are inhibitors of isocitrate dehydrogenase–1.

Updated Articles

Lipoprotein a…

Lipoprotein (a) is a modified form of LDL to which apolipoprotein (a), is covalently bound to apolipoprotein B100 (apoB). The molecular mass can vary between 275 and 800 kDa due to inheritance of more than 40 different allelic LPA variants that…

New Articles

CMV T Cell Immunity

Cytomegalovirus (CMV), a double-stranded DNA virus, belongs to the Herpesviridae family. The prevalence of CMV infection in adults ranges between 30 and 70%. Following CMV infection the virus spreads hematogenously to almost every organ. CMV then…

Blog

SARS-CoV-2…

Some experts estimate that exposure to as few as 1000 SARS-CoV-2 viral particles can cause an infection. This dose of virus could occur by inhaling 1000 infectious viral particles in a single breath, 100 viral particles in 10 breaths, or 10 viral…